The Regulatory, Compliance & Ethics track focuses on the critical frameworks that ensure clinical research and healthcare innovation are conducted responsibly, safely, and transparently. This track explores global regulatory pathways, approval processes, and compliance standards that govern drug development, medical devices, and emerging health technologies. Sessions will address Good Clinical Practice (GCP), data protection regulations, pharmacovigilance, and quality assurance systems designed to safeguard patient welfare and maintain scientific integrity. Emphasis will also be placed on harmonization efforts among international regulatory bodies to streamline approvals while upholding rigorous safety standards. In addition, the track examines ethical considerations in research, including informed consent, patient privacy, equitable participant recruitment, and the responsible use of emerging technologies such as artificial intelligence and genomics. Experts will discuss risk management strategies, audit readiness, transparency in reporting, and evolving policies that shape the future of healthcare research.